By Fergal Smith
TORONTO, June 10 (Reuters) – Canadian health company Apotex Health rose about 17% above the initial public offering price at its Toronto market debut on Wednesday, bringing life back to a subdued market that had struggled to see new IPOs for years.
Its shares opened at C$28, well above the IPO price of C$24.
(Reporting by Fergal Smith)
Brought to you by www.srnnews.com